The team at Metabolomic Diagnostics recognise the important contributions our investors and partners make every day to help us make pregnancies safer. If you would like to join us on our journey as an investor, collaborator or partner we would be delighted to hear from you, please contact us.
The company is a member of the IMPROvED consortium, which is a €6m EU funded project to recruit over 4,000 women through multiple centres (Sweden, Netherlands, UK and Ireland) to provide blood samples at multiple timepoints during their pregnancy, as well as detailed (anonymised) clinical data. The company’s portion of the resulting biobank, provides a rich research asset which will support its ongoing product development efforts.
Agilent Technologies have been a long-term supporter of the company and have supported its work through the provision of long-term loan equipment and technical expertise.
SOSV is the company’s lead investor.
AIB SCF managed by Enterprise Equity is an investor in the company.
Enterprise Ireland is the government agency responsible for the promotion of Irish enterprises involved primarily in international trade. Enterprise Ireland is an investor in the company and have provided funds to support the company’s research programs.
The Wellcome Trust is a shareholder in the company.
The Irish National Foetal And Neonatal Translational Research Centre (INFANT), whose goal is to become the world’s leading maternal and perinatal translational research centre.